{"entity":{"type":"insider","cik":"0001522780","url":"/insider/0001522780","json_url":"/insider/0001522780.json","name":"Kaye Edward M. MD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":31,"first":"2015-03-03","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Kaye Edward M. MD","source":"filing","n_filings":31,"first_seen":"2015-03-03","last_seen":"2026-08-18"}],"transactions":[{"id":9291175,"accession":"0001522780-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001522780-26-000007","line_url":"/filing/0001522780-26-000007","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12567.0,"shares_display":"12,567","price_per_share":32.03056224238084,"price_display":"32.03","price_state":"stated","total_value":402528.0757,"total_display":"402,528.08","total_whole":"402,528","shares_owned_after":124557.0,"shares_owned_after_display":"124,557","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-18","scope":"insider","n_lines":2},{"id":5768685,"accession":"0001061983-26-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-26-000066","line_url":"/filing/0001061983-26-000066#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2933.0,"shares_display":"2,933","price_per_share":76.09,"price_display":"76.09","price_state":"stated","total_value":223171.97,"total_display":"223,171.97","total_whole":"223,172","shares_owned_after":10283.0,"shares_owned_after_display":"10,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-01","scope":"insider"},{"id":4567817,"accession":"0001522780-25-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001522780-25-000010","line_url":"/filing/0001522780-25-000010","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13430.0,"shares_display":"13,430","price_per_share":32.26992290394639,"price_display":"32.27","price_state":"stated","total_value":433385.0646,"total_display":"433,385.06","total_whole":"433,385","shares_owned_after":50455.0,"shares_owned_after_display":"50,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider","n_lines":3},{"id":5013521,"accession":"0001522780-25-000009","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001522780-25-000009","line_url":"/filing/0001522780-25-000009","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8548.0,"shares_display":"8,548","price_per_share":31.324453392606458,"price_display":"31.32","price_state":"stated","total_value":267761.4276,"total_display":"267,761.43","total_whole":"267,761","shares_owned_after":64735.0,"shares_owned_after_display":"64,735","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-05","scope":"insider","n_lines":3},{"id":5013505,"accession":"0001522780-25-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001522780-25-000009","line_url":"/filing/0001522780-25-000009","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6453.0,"shares_display":"6,453","price_per_share":30.86897340771734,"price_display":"30.87","price_state":"stated","total_value":199197.4854,"total_display":"199,197.49","total_whole":"199,197","shares_owned_after":72333.0,"shares_owned_after_display":"72,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-05","scope":"insider","n_lines":2},{"id":5214479,"accession":"0001522780-25-000008","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001522780-25-000008","line_url":"/filing/0001522780-25-000008","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1070.0,"shares_display":"1,070","price_per_share":30.648107196261684,"price_display":"30.65","price_state":"stated","total_value":32793.4747,"total_display":"32,793.47","total_whole":"32,793","shares_owned_after":51305.0,"shares_owned_after_display":"51,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-03","scope":"insider","n_lines":2},{"id":5214463,"accession":"0001522780-25-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001522780-25-000008","line_url":"/filing/0001522780-25-000008","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1066.0,"shares_display":"1,066","price_per_share":29.782318480300187,"price_display":"29.78","price_state":"stated","total_value":31747.9515,"total_display":"31,747.95","total_whole":"31,748","shares_owned_after":52780.0,"shares_owned_after_display":"52,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-03","scope":"insider","n_lines":2},{"id":5077135,"accession":"0001061983-25-000040","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001061983-25-000040","line_url":"/filing/0001061983-25-000040#line-3","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28064.0,"shares_display":"28,064","price_per_share":66.72,"price_display":"66.72","price_state":"stated","total_value":1872430.08,"total_display":"1,872,430.08","total_whole":"1,872,430","shares_owned_after":9977.0,"shares_owned_after_display":"9,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-02","scope":"insider"},{"id":4166936,"accession":"0001061983-25-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000031","line_url":"/filing/0001061983-25-000031#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5175.0,"shares_display":"5,175","price_per_share":65.08,"price_display":"65.08","price_state":"stated","total_value":336789.0,"total_display":"336,789.00","total_whole":"336,789","shares_owned_after":9977.0,"shares_owned_after_display":"9,977","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-12","scope":"insider"},{"id":4649444,"accession":"0001522780-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001522780-25-000007","line_url":"/filing/0001522780-25-000007#line-2","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":49124.0,"shares_owned_after_display":"49,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider"},{"id":4063755,"accession":"0001061983-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-25-000008","line_url":"/filing/0001061983-25-000008#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6757.0,"shares_display":"6,757","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":405420.0,"total_display":"405,420.00","total_whole":"405,420","shares_owned_after":9778.0,"shares_owned_after_display":"9,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-06","scope":"insider"},{"id":4820357,"accession":"0001522780-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001522780-25-000004","line_url":"/filing/0001522780-25-000004#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42461.0,"shares_display":"42,461","price_per_share":25.0867,"price_display":"25.09","price_state":"stated","total_value":1065206.3687,"total_display":"1,065,206.37","total_whole":"1,065,206","shares_owned_after":49124.0,"shares_owned_after_display":"49,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider"},{"id":5041393,"accession":"0001061983-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-25-000006","line_url":"/filing/0001061983-25-000006#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6695.0,"shares_display":"6,695","price_per_share":55.08,"price_display":"55.08","price_state":"stated","total_value":368760.6,"total_display":"368,760.60","total_whole":"368,761","shares_owned_after":16535.0,"shares_owned_after_display":"16,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-09-30","scope":"insider"},{"id":4467638,"accession":"0001415889-25-023590","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-023590","line_url":"/filing/0001415889-25-023590#line-3","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45996.0,"shares_display":"45,996","price_per_share":20.1291,"price_display":"20.13","price_state":"stated","total_value":925858.0836,"total_display":"925,858.08","total_whole":"925,858","shares_owned_after":91585.0,"shares_owned_after_display":"91,585","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-03","scope":"insider"},{"id":4632706,"accession":"0001127602-25-021074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-021074","line_url":"/filing/0001127602-25-021074#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6756.0,"shares_display":"6,756","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":337800.0,"total_display":"337,800.00","total_whole":"337,800","shares_owned_after":23230.0,"shares_owned_after_display":"23,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-02","scope":"insider"},{"id":4467634,"accession":"0001415889-25-023590","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-023590","line_url":"/filing/0001415889-25-023590#line-2","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14860.0,"shares_display":"14,860","price_per_share":20.1386,"price_display":"20.14","price_state":"stated","total_value":299259.596,"total_display":"299,259.60","total_whole":"299,260","shares_owned_after":137581.0,"shares_owned_after_display":"137,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-03","scope":"insider"},{"id":4467632,"accession":"0001415889-25-023590","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023590","line_url":"/filing/0001415889-25-023590#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1029.0,"shares_display":"1,029","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":20580.0,"total_display":"20,580.00","total_whole":"20,580","shares_owned_after":152441.0,"shares_owned_after_display":"152,441","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-29","filed_date":"2025-09-03","scope":"insider"},{"id":4953224,"accession":"0001415889-25-022441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-022441","line_url":"/filing/0001415889-25-022441#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12126.0,"shares_display":"12,126","price_per_share":18.238,"price_display":"18.24","price_state":"stated","total_value":221153.988,"total_display":"221,153.99","total_whole":"221,154","shares_owned_after":153470.0,"shares_owned_after_display":"153,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-20","scope":"insider"},{"id":4350170,"accession":"0001127602-25-016870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-016870","line_url":"/filing/0001127602-25-016870#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3636.0,"shares_display":"3,636","price_per_share":32.1,"price_display":"32.10","price_state":"stated","total_value":116715.6,"total_display":"116,715.60","total_whole":"116,716","shares_owned_after":29658.0,"shares_owned_after_display":"29,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-05","scope":"insider"},{"id":4433432,"accession":"0001415889-25-008711","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008711","line_url":"/filing/0001415889-25-008711#line-2","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8907.0,"shares_display":"8,907","price_per_share":8.27,"price_display":"8.27","price_state":"stated","total_value":73660.89,"total_display":"73,660.89","total_whole":"73,661","shares_owned_after":139346.0,"shares_owned_after_display":"139,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-20","scope":"insider"},{"id":4433428,"accession":"0001415889-25-008711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008711","line_url":"/filing/0001415889-25-008711#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10382.0,"shares_display":"10,382","price_per_share":8.67,"price_display":"8.67","price_state":"stated","total_value":90011.94,"total_display":"90,011.94","total_whole":"90,012","shares_owned_after":148253.0,"shares_owned_after_display":"148,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":2565706,"accession":"0001415889-24-028928","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-028928","line_url":"/filing/0001415889-24-028928#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6786.0,"shares_display":"6,786","price_per_share":12.9912,"price_display":"12.99","price_state":"stated","total_value":88158.2832,"total_display":"88,158.28","total_whole":"88,158","shares_owned_after":61885.0,"shares_owned_after_display":"61,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-11","scope":"insider"},{"id":2757439,"accession":"0001415889-24-028890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-028890","line_url":"/filing/0001415889-24-028890#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6170.0,"shares_display":"6,170","price_per_share":12.7775,"price_display":"12.78","price_state":"stated","total_value":78837.175,"total_display":"78,837.18","total_whole":"78,837","shares_owned_after":68671.0,"shares_owned_after_display":"68,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-10","scope":"insider"},{"id":2278610,"accession":"0001415889-24-014087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-014087","line_url":"/filing/0001415889-24-014087","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42350.0,"shares_display":"42,350","price_per_share":15.431621232585597,"price_display":"15.43","price_state":"stated","total_value":653529.1592,"total_display":"653,529.16","total_whole":"653,529","shares_owned_after":29664.0,"shares_owned_after_display":"29,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider","n_lines":2},{"id":2329333,"accession":"0001415889-24-008683","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-008683","line_url":"/filing/0001415889-24-008683#line-2","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11150.0,"shares_display":"11,150","price_per_share":6.0986,"price_display":"6.10","price_state":"stated","total_value":67999.39,"total_display":"67,999.39","total_whole":"67,999","shares_owned_after":69350.0,"shares_owned_after_display":"69,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-19","scope":"insider"},{"id":6817119,"accession":"0001127602-22-020670","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-020670","line_url":"/filing/0001127602-22-020670#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11428.0,"shares_display":"11,428","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":571400.0,"total_display":"571,400.00","total_whole":"571,400","shares_owned_after":12576.0,"shares_owned_after_display":"12,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-08","scope":"insider"},{"id":4841280,"accession":"0001061983-21-000265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-21-000265","line_url":"/filing/0001061983-21-000265#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":675000.0,"total_display":"675,000.00","total_whole":"675,000","shares_owned_after":6765.0,"shares_owned_after_display":"6,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-23","scope":"insider"},{"id":2517880,"accession":"0001209191-20-064581","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-064581","line_url":"/filing/0001209191-20-064581#line-2","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5194.0,"shares_display":"5,194","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":311640.0,"total_display":"311,640.00","total_whole":"311,640","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-18","scope":"insider"},{"id":2517878,"accession":"0001209191-20-064581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-064581","line_url":"/filing/0001209191-20-064581#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19806.0,"shares_display":"19,806","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":1188360.0,"total_display":"1,188,360.00","total_whole":"1,188,360","shares_owned_after":5194.0,"shares_owned_after_display":"5,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-18","scope":"insider"},{"id":3285419,"accession":"0001209191-20-060751","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-060751","line_url":"/filing/0001209191-20-060751#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12152.0,"shares_display":"12,152","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":607600.0,"total_display":"607,600.00","total_whole":"607,600","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-27","filed_date":"2020-11-30","scope":"insider"},{"id":2976551,"accession":"0001209191-20-060558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-060558","line_url":"/filing/0001209191-20-060558#line-1","is_derivative":false,"issuer_cik":"0001522780","issuer_name":"Stoke Therapeutics, Inc.","issuer_ticker":"STOK","issuer_name_source":null,"issuer_url":"/issuer/0001522780","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12848.0,"shares_display":"12,848","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":642400.0,"total_display":"642,400.00","total_whole":"642,400","shares_owned_after":37152.0,"shares_owned_after_display":"37,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-25","filed_date":"2020-11-25","scope":"insider"},{"id":2637690,"accession":"0001061983-20-000161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-20-000161","line_url":"/filing/0001061983-20-000161#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":600000.0,"total_display":"600,000.00","total_whole":"600,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-05","scope":"insider"},{"id":4083941,"accession":"0001209191-17-046038","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-046038","line_url":"/filing/0001209191-17-046038#line-2","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":410000.0,"total_display":"410,000.00","total_whole":"410,000","shares_owned_after":52471.0,"shares_owned_after_display":"52,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":2478420,"accession":"0001209191-16-142786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-142786","line_url":"/filing/0001209191-16-142786#line-2","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (President, CEO & CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40179.0,"shares_display":"40,179","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":2410740.0,"total_display":"2,410,740.00","total_whole":"2,410,740","shares_owned_after":76983.0,"shares_owned_after_display":"76,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-22","filed_date":"2016-09-26","scope":"insider"},{"id":2060935,"accession":"0001209191-16-142357","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-142357","line_url":"/filing/0001209191-16-142357","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Director, Officer (President, CEO & CMO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24352.0,"shares_display":"24,352","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":1217600.0,"total_display":"1,217,600.00","total_whole":"1,217,600","shares_owned_after":76983.0,"shares_owned_after_display":"76,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-19","filed_date":"2016-09-21","scope":"insider","n_lines":3},{"id":2552405,"accession":"0001209191-16-141771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-141771","line_url":"/filing/0001209191-16-141771#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Officer (SVP Interim CEO & CMO)","role_mark":"O","role_mark_label":"Officer (SVP Interim CEO & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Interim CEO & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24557.0,"shares_display":"24,557","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":736710.0,"total_display":"736,710.00","total_whole":"736,710","shares_owned_after":76983.0,"shares_owned_after_display":"76,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-16","scope":"insider"},{"id":8704473,"accession":"0001325812-15-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001325812-15-000019","line_url":"/filing/0001325812-15-000019#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001522780","owner_name":"Kaye Edward M. MD","owner_display_name":"Kaye Edward M. MD","owner_url":"/insider/0001522780","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":11.815,"price_display":"11.82","price_state":"stated","total_value":9452.0,"total_display":"9,452.00","total_whole":"9,452","shares_owned_after":1311.0,"shares_owned_after_display":"1,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-27","filed_date":"2015-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":47,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001623526","name":"Stoke Therapeutics, Inc.","url":"/issuer/0001623526","role":"Director, Officer (CEO)","n_filings":16,"first_seen":"2020-11-25","last_seen":"2026-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001061983","name":"CYTOKINETICS INC","url":"/issuer/0001061983","role":"Director","n_filings":10,"first_seen":"2020-10-05","last_seen":"2026-06-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Director, Officer (President, CEO & CMO)","n_filings":5,"first_seen":"2015-03-03","last_seen":"2017-07-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001522780","retrieved_at":"2026-08-25T12:59:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}